Shionogi
  • About
    • About Shionogi
      • Our leadership team
      • History and values
      • Global affiliates and locations
      • Investor relations
  • Sustainability
    • Sustainability
      • Tax strategy
      • Transparency
      • Governance, policies and position statements
      • Carbon reduction plan
  • Innovation
    • Innovation
      • Our areas of focus
      • Strategic partnering in Europe
      • Global innovation
      • Grants and donations
  • News
  • Investors
  • Careers
  • Contact
Europe
Worldwide
  1. Home
  2. News
  3. Press Releases
  4. Shionogi and Purdue Pharma establish alliance for joint U.S. commercialisation of naldemedine
Release
2016/12/19

Shionogi and Purdue Pharma establish alliance for joint U.S. commercialisation of naldemedine

  • About
  • Sustainability
  • Innovation
  • Investors
  • News
  • Careers
  • Worldwide
  • Report Side Effect
  • Terms of Use
  • Cookie Policy
  • Contact Us
  • Sitemap
  • Privacy Policy
  • References
© Shionogi B.V. 2024. All rights reserved. This website is owned by Shionogi B.V. Registered with the Trade Register of the Dutch Chamber of Commerce under number 73229180. Registered address is Herengracht 464, 1017 CA, Amsterdam, the Netherlands.